one thing i was told is that the constant news flow that MSB has always enjoyed will continue.
if they can lock in a few more partnerships which fund the new areas then its great.
all we need is one product to get to market and we can light the blue touch paper.
Biotechs are a good area to be in due to the number of drugs coming off patent, big pharma need to buy new growth rather than try and invent the wheel which may not come off.
MSB is looking very strong and a year from now should be looking even brighter.
no stopping this now , page-4
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.010(0.91%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.11 | $1.07 | $4.794M | 4.399M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 14500 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 141676 | 5 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |